John D. Roberts

19.1k citations

268 papers · 15.5k indexed · 2 hit papers · h-index 55

Impact in

Virology top 0.5%
- HIV Research and Treatment
Genetics top 0.5%
- Hemoglobinopathies and Related Disorders
- Bacterial Genetics and Biotechnology

Papers in

Genetics 42
- Hemoglobinopathies and Related Disorders 25
- Chronic Lymphocytic Leukemia Research 16
Hematology 32

Co-authors: Thomas A. Kunkel Richard A. Zakour Katarzyna Bębenek Wally R. Smith Susan D. Roseff James L. Levenson Viktor E. Bovbjerg Imoigele P. Aisiku
Journals: Journal of the American Chemical Society (48 papers)Blood (14 papers)Journal of Biological Chemistry (13 papers)Proceedings of the National Academy of Sciences (13 papers)Biochemistry (10 papers)
Partner nations: United States Japan Canada

In The Last Decade

John D. Roberts

263 papers receiving 14.9k citations

Hit Papers

align trajectories log scale

The Accuracy of Reverse Transcriptase from HIV-1 1988 · 747 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1988 Science
1987 Methods in enzymology on CD-ROM/Methods in enzymology

Peers

Replace Charles S. Craik with:

Charles S. Craik United States

David P. Fairlie Australia

Richard A. Lerner United States

Piet Gros Netherlands

A. C. Allison United Kingdom

Pauline M. Rudd United Kingdom

Richard D. Klausner United States

Víctor E. Márquez United States

Paolo Ascenzi Italy

Stefan Knapp Germany

John D. Roberts relative to Charles S. Craik United States Charles S. Craik's profile →

Citations per field

00.5×1.5×1.8×

Charles S. Craik · 1×

×0.9 1k/1k

VIROL

×1.4 2k/1k

GENET

×0.7 8k/11k

MB

×0.8 1k/2k

HEMAT

×1.8 1k/648

SPECT

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by John D. Roberts

Since Specialization

Citations

This map shows the geographic impact of John D. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Roberts more than expected).

Fields of papers citing papers by John D. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Roberts. The network helps show where John D. Roberts may publish in the future.

Co-authors

The 25 scholars most cited alongside John D. Roberts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John D. Roberts Line = papers co-authored together John D. Roberts links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet Nature Communications ·Yufeng Qin, Sara A. Grimm, John D. Roberts, Kaliopi Chrysovergis, Paul A. Wade	2020	36
2	Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use Clinica Chimica Acta ·Christopher D. Koch, Liang Xu, Susanna A. Curtis, John D. Roberts, Dustin R. Bunch, Joe M El-Khoury	2020	4
3	Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints Cannabis and Cannabinoid Research ·Susanna A. Curtis, Amanda M. Brandow, Michelle DeVeaux, Daniel Zeltermam, Lesley Devine, John D. Roberts	2020	11
4	Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell program PLoS ONE ·Robert Rousseau, Daniel F. Weisberg, Jack Gorero, Vivek Parwani, Janis Bozzo, Kathleen Kenyon, Constance Smith, Joanna Cole, Susanna A. Curtis, Ariadna Forray, John D. Roberts	2020	4
5	GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network Nature Communications ·Motoki Takaku, Sara A. Grimm, John D. Roberts, Kaliopi Chrysovergis, Brian D. Bennett, Page Myers, L. Perera, Charles J. Tucker, Charles M. Perou, Paul A. Wade	2018	66
6	Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors Annals of Oncology ·Stuart J. Wong, Theodore Karrison, D. Neil Hayes, M.S. Kies, Kevin J. Cullen, Tawee Tanvetyanon, Athanassios Argiris, Naoko Takebe, Dean Lim, Nabil F. Saba, Francis P. Worden, Jeremy L. Gilbert, Heinz‐Josef Lenz, Albiruni Ryan Abdul Razak, John D. Roberts, Everett E. Vokes, Ezra E.W. Cohen	2015	73
7	A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2 Clinical Cancer Research ·Beata Holkova, Jeffrey G. Supko, Matthew M. Ames, Joel M. Reid, Geoffrey I. Shapiro, Edward Brent Perkins, Viswanathan Ramakrishnan, Mary Beth Tombes, Connie Honeycutt, Renee M. McGovern, Maciej Kmieciak, Ellen Shrader, Martha D. Wellons, Heidi Sankala, Austin Doyle, James R. Wright, John D. Roberts, Steven Grant	2013	26
8	Using Age-Based Life History Data to Investigate the Life Cycle and Vulnerability of Octopus cyanea PLoS ONE ·Jade N. Herwig, Martial Depczynski, John D. Roberts, Jayson M. Semmens, Monica Gagliano, Andrew Heyward	2012	30
9	PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma British Journal of Cancer ·Tasuku Matsuoka, Masakazu Yashiro, Nobuaki Nishioka, Kosei Hirakawa, Kenneth Olden, John D. Roberts	2012	40
10	Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation Clinical Cancer Research ·Guo Zhang, Margaret A. Park, Clint Mitchell, Hossein A. Hamed, Mohamed Rahmani, Aditi Pandya Martin, David T. Curiel, Adly Yacoub, Martin R. Graf, Ray Lee, John D. Roberts, Paul B. Fisher, Steven Grant, Paul Dent	2008	101
11	15‐Lipoxygenase‐1 activates tumor suppressor p53 independent of enzymatic activity International Journal of Cancer ·Hong Zhu, Wayne C. Glasgow, Margaret D. George, Kali Chrysovergis, Kenneth Olden, John D. Roberts, Thomas E. Eling	2008	16
12	P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin Experimental Cell Research ·Elsa M. Reyes‐Reyes, Margaret D. George, John D. Roberts, Steven K. Akiyama	2006	34
13	Increasing Hepatic Cholesterol 7α–Hydroxylase Reduces Plasma Cholesterol Concentrations in Normocholesterolemic and Hypercholesterolemic Rabbits Hepatology ·Guowang Xu, G Salen, Sarah Shefer, G C Ness, L. B. Nguyen, G. Stephen Tint, Thomas S. Parker, John D. Roberts, A K Batta, T S Chen, Zhihong Zhao, Xianglin Kong	1996	21
14	7 Fidelity of DNA Replication Cold Spring Harbor Monograph Archive ·John D. Roberts, Thomas A. Kunkel	1996	13
15	Nicotine is addictive, rules FDA BMJ ·John D. Roberts	1995	1
16	In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. Journal of Clinical Investigation ·J Li, Bingliang Fang, Randy C. Eisensmith, Xiaoxia Li, Igor O. Nasonkin, Yen Chiu Lin-Lee, Martha P. Mims, Adrienne Hughes, Chuck Montgomery, John D. Roberts	1995	58
17	Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum—carbon bond formation Journal of Inorganic Biochemistry ·Nicholas Farrell, John D. Roberts, (unknown), Miles P. Hacker, (unknown)	1991	18
18	A phase i clinical trial of didemnin B Cancer ·James A. Stewart, Jane B. Low, John D. Roberts, Alton J. Blow	1991	30
19	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne güntheri Peptides ·Maurizio Simmaco, Cinzia Severini, Daniela De Biase, Donatella Barra, Francesco Bossa, John D. Roberts, Pietro Melchiorri, V. Erspamer	1990	32
20	Some Aspects of Natural-Abundance Nitrogen-15 Nuclear Magnetic Resonance Spectroscopy Rice University's digital scholarship archive (Rice University) ·John D. Roberts	1980	1

About John D. Roberts

John D. Roberts is a scholar working on Genetics, Hematology, Spectroscopy, Biophysics and Pharmaceutical Science, having authored 268 papers that have together received 15.5k indexed citations. Recurring topics across this work include Molecular spectroscopy and chirality (26 papers), Hemoglobinopathies and Related Disorders (25 papers), DNA Repair Mechanisms (17 papers), Chronic Lymphocytic Leukemia Research (16 papers), NMR spectroscopy and applications (15 papers), Advanced NMR Techniques and Applications (14 papers), Electron Spin Resonance Studies (12 papers) and Protein Degradation and Inhibitors (12 papers). The work is most often cited by research in Virology (1.1k citations), Genetics (1.5k citations), Molecular Biology (7.9k citations), Hematology (1.2k citations) and Spectroscopy (1.1k citations). John D. Roberts has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Thomas A. Kunkel, Richard A. Zakour, Katarzyna Bębenek, Wally R. Smith, Susan D. Roseff, James L. Levenson, Viktor E. Bovbjerg, Imoigele P. Aisiku, Donna K. McClish and Lynne Penberthy. Their work appears in journals such as Journal of the American Chemical Society, Blood, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact